NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

August 31, 2005

Conditions
Erosive EsophagitisReflux EsophagitisGastroesophageal Reflux Disease
Interventions
DRUG

esomeprazole magnesium (oral medication)

Trial Locations (39)

Unknown

Research Site, Alabaster

Research Site, Anaheim

Research Site, Dinuba

Research Site, Fresno

Research Site, Orange

Research Site, San Diego

Research Site, Bridgeport

Research Site, Fort Lauderdale

Research Site, Hialeah

Research Site, Jacksonville

Research Site, Miami

Research Site, New Port Richey

Research Site, Zephyrhills

Research Site, Decatur

Research Site, Rome

Research Site, Savannah

Research Site, Oakbrook Terrace

Research Site, Urbana

Research Site, Louisville

Research Site, Covington

Research Site, Baltimore

Research Site, Chevy Chase

Research Site, Kalamazoo

Research Site, Troy

Research Site, Egg Harbor

Research Site, Passaic

Research Site, Brooklyn

Research Site, New York

Research Site, Chapel Hill

Research Site, Jacksonville

Research Site, Duncansville

Research Site, Pittsburgh

Research Site, North Providence

Research Site, Knoxville

Research Site, Dallas

Research Site, Ogden

Research Site, Bellevue

Research Site, Spokane

Research Site, Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY